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ABSTRACT 25 
Traditionally, the development of a new solid dosage form is formulation-driven and less focus is put on 26 
the design of a specific microstructure for the drug delivery system. However, the compaction process 27 
particularly impacts the microstructure, or more precisely, the pore architecture in a pharmaceutical 28 
tablet. Besides the formulation, the pore structure is a major contributor to the overall performance of 29 
oral solid dosage forms as it directly affects the liquid uptake rate, which is the very first step of the 30 
dissolution process. In future, additive manufacturing is a potential game changer to design the inner 31 
structures and realise a tailor-made pore structure. In pharmaceutical development the pore structure is 32 
most commonly only described by the total porosity of the tablet matrix. Yet it is of great importance to 33 
consider other parameters to fully resolve the interplay between microstructure and dosage form 34 
performance. Specifically, tortuosity, connectivity, as well as pore shape, size and orientation all impact 35 
the flow paths and play an important role in describing the fluid flow in a pharmaceutical tablet. This 36 
review presents the key properties of the pore structures in solid dosage forms and it discusses how to 37 
measure these properties. In particular, the principles, advantages and limitations of helium pycnometry, 38 
mercury porosimetry, terahertz time-domain spectroscopy, nuclear magnetic resonance and X-ray 39 
computed microtomography are discussed. 40 
Keywords: Pore structure, solid dosage form, terahertz technology, X-ray computed microtomography, 41 
mercury porosimetry, helium pycnometry, nuclear magnetic resonance 42 
1. Introduction	43 
The most widespread oral solid dosage form is the tablet, which is traditionally manufactured via powder 44 
compaction. Ideally, a blend of several excipients and one or more active pharmaceutical ingredients 45 
(APIs) is directly compressed to the desired shape, dimension, weight and hardness. However, in the 46 
majority of cases either wet or dry granulation has to precede the compaction step to achieve the targeted 47 
properties of the finished drug product (Leane et al., 2015). These additional process steps are primarily 48 
required due to the often inherently non-ideal API properties (e.g. particle size and morphology). API 49 
particles typically have a small particle size relative to excipient particles (Bellamy et al., 2008; Olusanmi 50 
et al., 2014) and frequently exhibit a needle-like shape (Tye et al., 2005; Waknis et al., 2013), which can 51 
result in poor powder flowability (Carstensen and Chan, 1976, Hart, 2016, Hirschberg, Sun and Rantanen, 52 
2016), segregation (Olusanmi et al., 2014), and unwanted adhesion to surfaces (e.g. tablet punches) (Lam 53 
and Newton, 1992, Paul et al., 2017a, Paul et al., 2017b). Granulation (Gabbott et al., 2016; Markl et al., 54 
2017a; van den Ban and Goodwin, 2017; Wikberg and Alderborn, 1990) and compaction (Alderborn et al., 55 
1985; Markl and Zeitler, 2017; Nordström et al., 2013) strongly influence the internal structure of the final 56 
tablet. The pores created by the process (interparticle pores) and the intraparticle pores, if present, of 57 
each constituent particle result in a complex architecture of void space in the tablet, which impacts the 58 
performance of the dosage form. Recent developments are towards engineering particles to improve 59 
powder flowability (Trementozzi et al., 2017, Chattoraj and Sun, 2018) and compressibility (Chattoraj and 60 
Sun, 2018). 61 
Both interparticle pore space and interparticulate bonds are created during compaction. This process 62 
typically consists of several steps: i) granular material is metered into a cavity formed by two punches and 63 
a die, ii) rearrangement of particles iii) elastic deformation, iv) plastic deformation and v) fragmentation 64 
(Duberg and Nyström, 1986). In addition to these five compaction steps, tabletting also includes the 65 
relaxation of the compact resulting in a change of the tablet volume. Every single step has an impact on 66 
the final void space, which eventually controls the fluid flow and liquid transport through the solid dosage 67 
form. In particular, liquid imbibition is the first, and often the rate-determining, step in the disintegration 68 
of immediate-release tablets (Nogami et al., 1967). Although the liquid uptake process does not directly 69 
cause the break-up of the dosage form, it is a prerequisite to initiate other disintegration mechanisms, 70 
such as swelling, that build up the pressure necessary to rupture the interparticulate bonds (Markl and 71 
Zeitler, 2017). Disintegration mechanisms and methods to characterise these phenomena were recently 72 
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reviewed by Desai, Liew and Heng, 2016, Quodbach and Kleindebudde, 2016 as well as by Markl and 73 
Zeitler, 2017. 74 
The void space of pharmaceutical solid dosage forms is typically not created by design but rather it is a 75 
by-product of the compaction process. Therefore, in the majority of cases it is characterised by a complex 76 
and frequently random architecture of pores of different sizes, shapes and orientations (Figure 1). Most 77 
of the pores are connected to each other as well as to the surface via small throats (open pores), however 78 
some pores are sealed-off (closed pores) from the connected structure. The connected pores form 79 
tortuous capillaries through which the physiological fluid flows and enters the dosage form upon 80 
ingestion. Moreover, it is well-known that powder compaction yields directionally dependent mechanical 81 
properties (hardness and strength) of a tablet (Akseli et al., 2009; Edge et al., 2001; Mullarney and 82 
Hancock, 2006; Wu et al., 2008), yet the resulting anisotropic pore structures are studied far less. It is, 83 
however, of great importance to investigate the effect of manufacturing route and process parameters 84 
on the microstructure of the intermediate and final product to achieve reproducible product quality 85 
(Westermarck et al., 1998a; 1998b; 1999). A better understanding of the relationship between material 86 
properties, manufacturing process parameters and the evolution of tablet microstructure will eventually 87 
lead to design and engineer the tablet microstructure, as recently reviewed by Sun, 2016. 88 
The effect of the pore structure on the performance is not only relevant for tablets manufactured via 89 
powder compaction – it is also of critical importance for 3D printed drug delivery systems. Additive 90 
manufacturing, or 3D printing, enables the manufacture of highly porous and complex solid dosage forms 91 
which were previously considered impossible to create. These porous structures can be designed such 92 
that they disintegrate within seconds upon contact with dissolution liquid (Norman et al., 2017). The most 93 
common printing technologies in the context of solid dosage form manufacturing are fused deposition 94 
modelling (FDM) (Goyanes et al., 2015a; 2015b; Khaled et al., 2015) and the powder based 3D printing 95 
method developed at MIT and commercialised (getting a new product or service introduced into the 96 
general market) as the ZipDose technology (Aprecia Pharmaceuticals Company; Fina et al., 2017; Katstra 97 
et al., 2000; C. W. Rowe et al., 2000). In FDM, a polymer strand is heated, extruded and then deposited 98 
layer-by-layer to create a 3D object. It was recently demonstrated that this process generates a strongly 99 
anisotropic pore structure (Markl et al., 2017c), which influences the drug release kinetics. In the case of 100 
powder based 3D printing, the 3D printed object is built up by adding a binding solution and applying a 101 
new layer of powder on top, and repeating these steps. Within powder based 3D printing, Parteli and 102 
Pöschel, 2016 have recently highlighted how crucial it is to develop a better understanding of the packing 103 
behaviour of the powder bed, as it determines the fusion process between layers.  104 
It has been demonstrated for porous media (Cai and Yu, 2011; Dullien, 1992) in general but also for 105 
pharmaceutical tablets (Markl et al., 2018b) that the tortuosity, connectivity, as well as pore shape, size 106 
and orientation affect the liquid imbibition process (Figure 1). To advance the understanding of the 107 
relationship between the manufacturing process and the performance of the final drug product, it is 108 
essential to quantitatively measure, and to routinely report, these characteristic pore parameters in a 109 
tablet in addition to the commonly used descriptor of tablets, namely total porosity or solid fraction. 110 
The pore structure of pharmaceutical solid dosage forms can be characterised by a number of different 111 
techniques (Figure 2). The methods exploit a range of physical phenomena to determine various 112 
macroscopic and microscopic pore parameters. The methods can be divided into two main categories: 113 
void space- and matrix-sensitive techniques. Void space-sensitive methods use a fluid (gas or liquid) to 114 
directly access the pore volume in the sample. These techniques include helium pycnometry (see section 115 
3), mercury porosimetry (see section 4), nitrogen adsorption (Ferrero and Jiménez-Castellanos, 2002; 116 
Westermarck et al., 1999; 1998a) as well as thermoporometry (Faroongsarng and Peck, 2003; Iza et al., 117 
2000; Luukkonen et al., 2001). Cost-effective and simple analysis using an oil absorption method has been 118 
reported for the measurement of the porosity of non-uniform ribbons from a roller compaction process 119 
(Khorasani et al., 2015a). Since void-space sensitive techniques use a fluid to directly probe the pores, 120 
they only provide a measure of the open/connected pores which are accessible from the surface.  121 
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Matrix-sensitive methods typically use electromagnetic radiation to probe the sample. These methods 122 
yield a measure of the pore space by either using additional information about the sample (e.g. 123 
dimensions or optical properties of the solid material) or applying specifically-developed data processing 124 
procedures to separate the solid material from the voids (e.g. thresholding for image-based techniques). 125 
2D imaging methods (surface-sensitive), such as optical microscopy, scanning electron microscopy (SEM) 126 
(Andersson et al., 2013; Boissier et al., 2012; Häbel et al., 2016; Wu et al., 2008; 2005; 2007; 2006), 127 
transmission electron microscopy (TEM) (Eddleston et al., 2010) and atomic force microscopy (AFM) 128 
(Tuntikulwattana et al., 2010) can be applied to determine structural parameters of the sample at the 129 
surface or at cross-sections by cutting or breaking the sample. The samples are often frozen using liquid 130 
nitrogen before they are cut or broken at a predefined breaking point to avoid smearing and plastic 131 
deformation of the sample that may damage the pore structure. However, these measurements may not 132 
be representative of the sample as they probe only the surface, and 3D information about the pores can 133 
only be estimated by making assumptions about the shape of the pores. The meaning of 2D 134 
measurements in 3D volumes can be investigated with the aid of stereological conversions and/or 3D 135 
texture models (Jerram and Higgins, 2007; Jerram and Kent, 2006).  136 
There are also several techniques utilising electromagnetic radiation that are sensitive to the volume of 137 
the pores. These methods include focused ion beam SEM (FIB-SEM) (Heng et al., 2007; Moghadam et al., 138 
2006; Palmas et al., 2016; Poozesh et al., 2017), confocal laser scanning microscopy (CLSM) (Barman and 139 
Bolin, 2017; Häbel et al., 2017; Marucci et al., 2013), nuclear magnetic resonance (NMR, see section 5), X-140 
ray computed microtomography (XµCT, see section 6), and terahertz time-domain spectroscopy (THz-TDS, 141 
see section 7). NMR is also a void-space sensitive method as it utilises the interaction of the liquid in the 142 
pores and solid phase to reveal structural properties of the porous medium. A laser-based method has 143 
also been reported to measure the porosity of ribbons by measuring the weight by a precision weighing 144 
module as well as the thickness of the sample by two laser displacement sensors (Allesø et al., 2016).  145 
These and several other techniques are well-known and routinely applied in geology (Anovitz and Cole, 146 
2015), where the pore structure plays an important role. It controls fluid storage in aquifers, oil/gas fields 147 
and geothermal systems as well as fluid flow and transport through geological formations. Other matrix-148 
sensitive techniques used outside the pharmaceutical field are ultrasmall-angle X-ray (USAXS) (Lee et al. 149 
2014) and ultrasmall-angle neutron scattering (USANS) (Clarkson et al., 2012; Mastalerz et al., 2012). 150 
The destructive nature and the relatively long measurement times of most of these techniques render 151 
them incapable of characterising pore structures in an at-line, on-line or in-line setting. There is a need in 152 
the pharmaceutical industry for process analysers that can be integrated in a manufacturing line and 153 
provide almost real-time measures of the pore structure. This has been demonstrated using near-infrared 154 
spectroscopy (NIRS) for roll compaction and tabletting (Khorasani et al., 2015b). However, NIRS does not 155 
probe a physical attribute of the material that is directly related to a characteristic property of the pore 156 
structure. It measures the surface gloss and it is assumed that this gloss measurement is correlated to the 157 
porosity. Another promising technology for in-process control is the novel terahertz-based porosity 158 
measurement. This rapid and simple approach has the potential to be applied as a process monitoring 159 
tool, as discussed in section 8. 160 
This review begins with discussing the characteristic and performance-determining pore properties based 161 
on exemplification. It then presents and critically discusses the state-of-the art and emerging technologies 162 
to determine pore parameters of pharmaceutical materials. This includes the discussion of mercury 163 
porosimetry and helium pycnometry as well as three methods exploiting the interaction of 164 
electromagnetic radiation with porous materials, namely XµCT, NMR and THz-TDS. This review presents 165 
their principles and applications on pharmaceutical materials, but we also refer occasionally to 166 
applications, methods and processing procedures from other areas to provide a full picture of the 167 
capabilities of each technique. The final section of this article discusses the advantages and disadvantages 168 
of each technique.  169 
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2. Pore	Analysis 170 
Quantitative and descriptive pore parameters are needed to capture the sample microstructure. For the 171 
purpose of this review, any void space within the tablet boundary is considered a pore. 172 
To illustrate the various pore parameters, an example dataset is used throughout this section. These data 173 
were acquired by XµCT of 3D printed tablets (the technique and data acquisition are elaborated on in 174 
section 5). The printing was performed using a Makerbot Replicator 2 desktop 3D printer (New York, NY, 175 
US) and the material used was poly(vinyl alcohol). For the first two layers, the printing nozzle moved in a 176 
circular motion, and for subsequent layers it printed a parallel strand pattern, which was rotated by 90° 177 
between layers. Hence, a high degree of anisotropy is expected in the pore formation. The tablet form 178 
was a simple disk (height, ! = 1.5 mm and diameter, " = 10 mm), as illustrated in Figure 3, that was 179 
designed using Comsol Multiphysics (Comsol, Stockholm, Sweden, v5.1). Two samples were printed with 180 
the same print resolution (0.1 mm), however one was printed at a lower temperature (220°C, referred to 181 
as P1) compared to the other (230°C, referred to as P2).  182 
2.1 Porosity	and	Pore	Size	183 
The pore structure is commonly described by one single parameter, the total porosity, which is a measure 184 
of all the void space contained within the geometric boundaries of the dosage form and it includes the 185 
closed as well as the open pores. Porosity is expressed as # = %p,total/%, where %p,total  is the total pore 186 
volume, and % is the total sample volume (Rouquerolt et al., 1994).  187 
After identifying and separating individual pores from the dataset (Figure 4) the pore size distribution can 188 
be characterised. This gives the spread of pores by volume, surface area, equivalent diameter etc. It is 189 
rotation-independent.  190 
2.2 Tortuosity	191 
In general, low to high tortuosity describes, respectively, how linear to twisted the pore space structure 192 
is (Julbe and Ramsay, 1996). A commonly used definition is - = .e/.  where - is a dimensionless number 193 
relating the average length of the fluid path, .e, and the geometrical length of the sample, . (Figure 1). 194 
This explains how much farther a liquid must flow through the pores compared to the direct distance with 195 
respect to the physical length of the sample. A 3D description is the tortuosity tensor, which describes 196 
how the flow of individual streamlines in a pore deviate from the overall macroscopic flow in the pore 197 
(Dullien, 1992). In general, tortuosity depends on two key relations. Firstly, - ≥ 1, i.e. a given volume 198 
element of fluid must travel further to cover the same distance in a porous medium compared to simple 199 
straight pipe flow: passing through a porous material involves covering an additional distance. Secondly, 200 lim4→6 - = 1, i.e. as the medium becomes more porous, the tortuosity approaches 1, in that the pores are 201 
straight and no longer twisted. Using these relations, there are many models relating tortuosity and 202 
porosity in the literature, and their use depends on the specific application and material in question 203 
(Boudreau, 1996).  204 
For a packed bed, a tortuosity factor can be defined as - = .789:/!, where .789: is the continuous pore 205 
void length and ! is the bed height. This can be related to the mean pore velocity ; = ;8-/# (Comiti and 206 
Renaud, 1989), where ;8 is the overall superficial bed velocity and # is the bed void fraction. The mean 207 
velocity of fluid in a pore is faster than the overall superficial bed velocity and it increases with decreasing 208 
porosity. The tortuosity factor, however, increases the inside pore speed compared to the overall 209 
superficial bed velocity. The tortuosity factor is higher in parallelepiped packings than in spherical 210 
packings. The tortuosity and void fraction in a packed bed are also related through the equation - = 1 −211 = ln #, where = is a fitting parameter that is determined experimentally (Comiti and Renaud, 1989). 212 
Tortuosity factors can also be defined in terms of diffusion coefficients, as molecules diffuse under a 213 
concentration gradient (Weissberg, 1963), for instance -? = #"@/":AA, or as per Maxwell’s formula, - =214 1 + 6? (1 − #). "@/":AA is the diffusion coefficient of the diffusing species in a free fluid, "@, relative to its 215 
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value in a porous medium, ":AA  (Ghanbarian et al., 2013). It has been claimed in the geophysical field that 216 
this diffusion-based tortuosity is similar to the electrical tortuosity that is related to the electric 217 
conductivity of a material (Ben Clennell, 1997). Boudreau and Meysman, 2006 developed a model, - =218 1 + E?FGπ (1 − #), based on an assembly of non-penetrating and non-overlapping blocks to predict the 219 
tortuosity of muds. These disk-shaped blocks are described by the factor I that represents their radius to 220 
thickness ratio. The model was also shown to describe the relationship very well between porosity and 221 
tortuosity for functionalised calcium carbonate (FCC) tablets (Markl et al., 2018b). Wu et al., 2006 222 
determined the fastest route through the pore space of sodium chloride compacts by analysing cross-223 
sections of the tablets using SEM. The authors measured the relative path length from the SEM images 224 
and proposed this as a measure of the tortuosity. This characterisation revealed that the particle size 225 
influences the measured relative path length. Furthermore, the results indicated an anisotropic structure 226 
with the pores preferentially oriented in the direction of compression. This preferred directional 227 
orientation of pores could also be observed for FCC tablets (Markl et al., 2017b,2018a). 228 
2.3 Connectivity	229 
Yang et al., 2014 characterised packed ore particle beds by considering pore connectivity, which is 230 
especially important to determine the leaching from pores. Analogies can be drawn to that of solubilised 231 
drug diffusion through a tablet. Pore connectivity is defined as the summed volume of the individual pore 232 
clusters, identified by a suitable image analysis algorithm, divided by the total pore volume of the sample 233 
containing the clusters (Yang et al., 2014). A variation on this pore connectivity index is pore interface 234 
area divided by total surface area, where interface area is shared by two or more pores. The higher the 235 
proportion of interface area, the higher the pore connectivity (Axelsson and Svensson, 2010). Gutiérrez 236 
et al., 2014 took a different approach, defining interconnectivity of aluminides in AlCu7 alloys as the 237 
volume of the biggest dendritic aluminide divided by the total volume of aluminides. Another parameter 238 
to describe the connectivity of pores is percolation, which Fusseis et al., 2012 calculated using a 239 
parallelepiped box that moves through the sample volume in a grid-like fashion. This results in a 240 
probability function for percolation in different directions. Liu, Pereira, and Regenauer-Lieb, 2014 241 
performed a similar analysis with porous heterogeneous carbonate. More complex and lesser used 242 
parameters include Mandelbrot’s succolarity and lacunarity (Anovitz and Cole, 2015).  243 
2.4 Anisotropy	244 
Pore orientation and anisotropy can be determined from three perpendicular eigenvectors defining the 245 
principal axes of a pore (JK,	JM and	JN) describing its orientation in space (Figure 1). JK corresponds to 246 
the longest dimension of the pore and JM corresponds to the second longest dimension that is 247 
perpendicular to JK. Finally, JN is the third longest dimension that is perpendicular to both JM and JN. 248 
Each of these eigenvectors has an eigenvalue, O6, O? or OE, respectively. Problems arise when a porosity 249 
detection algorithm interprets a cluster of pores as a single large pore, rather than as several small ones 250 
– hence, an additional algorithm is needed to separate connected pores before anisotropic analysis can 251 
be applied.  252 
Fusseis et al., 2012 investigated dehydrating polycrystalline gypsum pores by using the ratio of the largest 253 
eigenvalue divided by the smallest eigenvalue for each pore. They disregarded both very large pores (> 1 254 
200 voxels) and very small pores (< 50 voxels), whose shape is not adequately described in this way. 255 
Axelsson and Svensson, 2010 plotted anisotropies of pores along different sample planes to characterise 256 
the structure of paper. To visualise the angular orientation of irregular pores in carbon-composite 257 
materials, Drach et al., 2013 created a spherical probability density function, which is volume weighted to 258 
account for the reduced contribution of smaller pores.  259 
A simpler approach was presented by Claes et al., 2016 by plotting JK for each pore on a 3D unit sphere 260 
(Figure 5). The trend for both the samples illustrated is that many larger pores are oriented in the RS 261 
plane, demonstrating their alignment along the printing direction. It is therefore possible to infer the RS 262 
7 
 
 
printing orientation, due to two clusters of pores at approximately 90° to one another. Smaller pores have 263 
more random orientations and hence they are dispersed almost evenly around the sphere.  264 
2.5 Permeability	265 
The resistance to flow in a porous bed is described by the factor T = U/V where U is fluid viscosity and V 266 
is the permeability. This resistance depends on the pore structure network of the bed, and gives rise to a 267 
pressure drop. If the fluid is exposed to an increased internal surface area per unit length of the sample, 268 
viscous drag increases, which, in turn, increases resistance to flow (Holdich, 2002). To understand 269 
permeability it is important to emphasise that it is determined by the flow behaviour through a saturated 270 
porous medium and thus the permeability is related to both its porosity and tortuosity. The equivalent 271 
hydraulic radius is a useful metric to describe fluid flow in porous structures, considered to be the radius 272 
of a single cylindrical pipe that exhibits the same flow resistance as the overall porous medium. The 273 
hydraulic radius itself cannot be defined by observing the overall porous medium physical structure 274 
(Costa, 2006), but can be approximated with significant assumptions by modelling, involving 3D 275 
minimisation of structure path lengths (Matthews et al., 1993). It is defined as the volume of fluid flowing 276 
across a unit cross-sectional area of the sample per unit sample length, divided by the surface area it 277 
touches, i.e. it can be described by WX = %YZ[/\, where %YZ[ is the saturated pore volume, and \ is the pore 278 
surface area (Rouquerolt et al., 1994). It is frequently used to predict permeability properties of the 279 
sample, and influences material response to processes such as drying and mechanical loading (Scherer, 280 
1994). To understand flow, the Reynolds number, T], is commonly used, which must be modified for a 281 
porous medium. The length dimension is given as the hydraulic radius, which for a porous bed becomes 282 ^ = 	 4(6_4)`a where bc is the specific surface area per unit volume. Thus, T] = def(6_4)`ag	(Holdich, 2002). At 283 
low T] < 2, the flow is considered laminar and can be described by Darcy’s law and the Carman-Kozeny 284 
equation. Darcy’s law can be used to determine the permeability of the bed experimentally, whereas 285 
Carman-Kozeny creates an analytical expression for the permeability, V = 4ij(6_4)k`ak, where l is the 286 
Kozeny constant, which is likely dependent on # based on experimental findings (Holdich, 2002). It is 287 
derived from Darcy’s law in conjunction with Poiseuille’s law, by modelling pores as cylindrical tubes 288 
(Costa, 2006). 289 
2.6 Shape	290 
To gain more insight into the spatial distribution of pores, cumulative porosity plots of the RS, Sm and Rm 291 
planes can be obtained by summing the number of voxels classified as voids along each dimension m, R 292 
and S, respectively, as done by Reh et al., 2012 and shown in Figure 6. The colour map depicts the void 293 
fraction at each point, i.e. the number of void voxels in a column divided by the total number of voxels in 294 
a column. To analyse the spatial distribution of pores further, the void voxels can be averaged in each RS 295 
plane and plotted by height m. 296 
Pore shape can be classified using particle characterisation techniques, such as Blott and Pye’s (Blott and 297 
Pye, 2008) elongation ratio n/. and flatness ratio b/n, which assign particles to form classes. . is the 298 
longest dimension, n is the longest dimension perpendicular to ., and b is perpendicular to both n and .. 299 
Schmitt et al., 2016 used Blott and Pye’s approach to analyse pores in German sandstone rocks using Feret 300 
calliper diameter measurements to obtain the relevant lengths. Claes et al., 2016 obtained n, . and b with 301 
moments of inertia to find the principal axes of an ellipsoid approximating each pore in carbonate 302 
reservoir rocks. This concept can be illustrated for the sample tablets: the pore eigenvalues give an 303 
indication of the pore size in perpendicular dimensions, allowing the elongation ratio, n/. = O2/O1 and 304 
flatness ratio, b/. = OE/O? to be calculated. In the example dataset the large pores from P1 (Figure 7a) 305 
and P2 (Figure 7b) lie close to the axes and the origin, indicating a blade-like shape of the large pores 306 
(Figure 7b). 307 
An extension is to include sphericity (Wadell, 1935) in the m axis,	opi(6%p)ki/bF,where bp is pore surface 308 
area and %p is pore volume. In general, smaller pores show a higher sphericity (Figure 7c and d). For the 309 
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larger pores, the more tubular, grid-like pores are expected to have a lower sphericity than round/bubble-310 
shaped pores.  311 
Further shape parameters can be found in the literature, with simple ones including surface area to 312 
volume ratios used by Reh et al., 2012 to describe pores in carbon fibre reinforced polymers. More 313 
intricate descriptions include pore compactness (Claes et al., 2016) and Gaussian curvature, which Tolnai 314 
et al., 2009 used to characterise dendritic solidification of AlMg4.7Si8. 315 
3. Helium	Pycnometry  316 
Helium pycnometry is used to obtain a key parameter for porous samples: the true solid density. This can 317 
be used in conjunction with the bulk density to calculate the total pore volume and the sample porosity. 318 
It does not give information on individual pore sizes, pore shape, pore orientation etc. The measurement 319 
apparatus involves two chambers – a sample chamber where the sample is inserted (of volume %c), and a 320 
reference chamber (of volume %r), which are connected by a pressure transducer as shown in Figure 8. 321 
The sample chamber is filled with helium to pressure =c. Helium demonstrates close to ideal gas 322 
behaviour, and hence is the test gas of choice. Given their small size, helium atoms are able to penetrate 323 
into very fine pores. Helium is considered inert and it is assumed that helium is neither adsorbed nor 324 
absorbed within the solid material (Lowell et al., 2004). The pressure of the sample chamber is recorded 325 
and then the valve to the reference chamber is opened and allowed to equilibrate to =9 (the equilibrated 326 
pressure in the reference and sample chambers), which is recorded. 327 
The true density and eventually the porosity of a sample can be derived using the ideal gas law, and 328 
applying it to different control volumes (Lowell et al., 2004). The measurement must be performed at 329 
constant temperature to be valid. The relationship between the solid, void and reference volumes is given 330 
by the following equation (Lowell et al., 2004): %Y8tuv = %w + xy6_z{zy	, where %Y8tuv is the solid volume (not to 331 
be confused with %, the total sample volume including pores). The true density of the object, which refers 332 
to the density of just the solid part, is given by the |[9}: = ~/%Y8tuv where ~ is the weight of the sample. 333 
This can be related to the porosity as # = 1 − |}tÄ/|[9}:, where |}tÄ is the bulk density of the sample.  334 
Unless there are closed, non-penetrable voids, helium pycnometry gives an accurate value of the true 335 
density of a material. If there are any gaseous particles that could be outgassed from the solid during the 336 
pressure changes, the sample must be degassed first. However, certain substances cannot be tested using 337 
helium as they release water under these conditions, which distorts the measurement and destroys the 338 
sample. For instance, the porosity of microcrystalline cellulose (MCC) is generally overestimated by 339 
approximately 3.6 – 14.2% due to this phenomenon, and, hence, must be dried adequately beforehand 340 
(Sun, 2005). This is particularly important for the characterisation of hygroscopic excipients using helium 341 
pycnometry. Many true density values in the literature may thus be erroneous and these materials need 342 
to be carefully re-examined.  343 
The helium pycnometer porosity reading is somewhat dependent on the applied pressure: at higher 344 
pressures, helium can penetrate into smaller voids, meaning the porosity will be recorded as being higher. 345 
This limitation depends on the length scale of the pores in question (Klaja and Przelaskowska, 2015). For 346 
some samples, the apparent true density decreases when a powder is compacted to a tablet – this can be 347 
explained by an increased frequency of closed pores through which the helium cannot penetrate (Alkhatib 348 
et al., 2010). 349 
The measurement using commercial instruments, such as the AccuPyc II 1340, can be made in 350 
approximately 3 min. Prior to measuring, the AccuPyc II 1340 completes purging cycles to clean the 351 
sample. It then takes several successive measurements until they converge to the same result 352 
(Micromeritics Instrument Corp., 2017). Quantachrome Instruments state that their gas pycnometers can 353 
analyse data in as little as one minute (Quantachrome Instruments, 2017).354 
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Table 1: A selection of helium pycnometry applications for porous pharmaceutical materials from recent literature. Information not given is indicated with ‘N/A’. 355 
‘!’ refers to the temperature of the measurement. Of interest is that few papers note the relative humidity conditions and the maximum pressures used for 356 
measurement. 357 
358 Author  Date Measuring device Material " (°C) Repeat 
(Alkhatib et al., 2010) 2010 
Ultrapycnometer 
1000 
(Quantachrome) 
Polyvinyl acetate–polyvinyl pyrrolidone 
matrices with MCC, dibasic calcium 
phosphate and D-lactose 
25 Minimum 6 per sample 
(Schiffter et al., 2010) 2010 Pycnomatic ATR (ThermoFisher) 
Spray freeze dried insulin loaded 
microparticles for needle-free ballistic 
powder delivery 
20 20 initial cleansing cycles and then 6 measurements per sample 
(Schrank et al., 2012) 2012 AccuPyc II 1340 (Micromeritics) 
Ibuprofen-loaded calcium stearate pellets 
with different drying conditions 20 
20 purges to 1.34 bar and 5 analytical runs, 
with each sample measured 3 times 
(Khomane and Bansal, 2013) 2013 
Pycno 30 
(Smart Instruments) 
Ranitidine hydrochloride polymorph tablets 25 3 per sample 
(Pircher et al., 2015) 2015 
Accupyc II 1340 
(Micromeritics) 
Dual porous biocompatible cellulose 
scaffolds 27 400 measurements per sample 
(Yassin et al., 2015b) 2015 
Accupyc 1330  
(Micromeritics) 
Hydroxypropylmethyl cellulose (HPMC), 
Eudragit RSPO and lactose tablets N/A 
Chamber is pressurised to 10 bar 30 times, 
after which measurement is recorded. 
(Yassin et al., 2015a) 2015 Accupyc 1330 (Micrometrics) 
MCC and croscarmellose sodium (CCS) 
tablets N/A 
Chamber is pressurised to 10 bar 30 times, 
after which measurement is recorded. 
(Pircher et al., 2016) 2016 
Accupyc II 1340 
(Micromeritics) 
Cellulose II aerogels made with different 
solvents 27 400 measurements per sample 
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4. Mercury	Porosimetry		359 
Penetration of liquid under pressure can be employed to determine the size and volume of void spaces in 360 
a porous medium. This principle works only with liquids that exhibit a contact angle with the solid greater 361 
than 90° as it will then resist wetting the solid and so can be intruded in pores controllably as a function 362 
of applied pressure. Mercury has a contact angle >90° for very many materials, and it is, therefore, the 363 
liquid of choice for such measurements. Mercury is forced under increasing pressure initially into the large 364 
pores and then progressively into the finer pores of the porous sample (Figure 9a). The volume of liquid 365 
forced into the pores increases as the pressure increases. By assuming a cylindrical pore shape, the Young-366 
Laplace equation, !" = 4%&' cos + /- is then utilised to determine the pore diameter !" at each pressure, 367 
P. The liquid-vapour surface tension of mercury (%&' = 0.485 N m-1) and the liquid-solid contact angle, +, 368 
for the given sample with mercury need to be known. Thus, in practice, mercury porosimetry measures 369 
the intruded volume in relation to the mass of the sample at a range of defined pressures. Increasing the 370 
pressure - on a material with a specific pore size distribution yields a unique cumulative pressure-volume 371 
curve, which permits the calculation of the pore volume as a function pore size (Figure 9b and c). 372 
Mercury porosimetry was introduced to the pharmaceutical field by Strickland, Busse, and Higuchi, 1956 373 
to measure the apparent density of granulates and the intragranular porosity. Reich and Gstirner, 1968 374 
developed a mercury porosimeter that made it possible to measure from very low to high pressures 375 
continuously, which could thus be used to determine the pore sizes ranging from 0.05 to 500 µm. This 376 
was demonstrated with the example of starch tablets, where the authors showed that an increase in 377 
compression force resulted in a decrease in porosity and pore radius, as well as an extended disintegration 378 
time of these tablets. These publications and others published before 1981 are summarised in an excellent 379 
review article from Dees and Polderman, 1981.  380 
Mercury porosimetry (together with helium pycnometry and nitrogen adsorption) is nowadays one of the 381 
most popular methods to measure the pore size distribution and porosity of pharmaceutical powders, 382 
granules and tablets (Table 2). Ohno et al., 2007, investigated the effect of changing process parameters 383 
of high shear wet granulation on the granule properties and the dissolution behaviour of mefenamic acid 384 
tablets. They found that an increase in water amount and kneading time caused an increase in the particle 385 
diameter of the granules and a decrease in the mean pore diameter. It was also observed that the larger 386 
the mean pore diameter of the granules, the more mefenamic acid API was released after 15 min. This 387 
clearly indicates that the initial dissolution behaviour is strongly affected by the pore structure of the 388 
granules. Riippi et al., 1998, demonstrated that the pore size distribution correlates with the dissolution 389 
behaviour of erythromycin acistrate tablets. However, they also indicated that the dissolution behaviour 390 
cannot be explained only by the volume of intruded mercury, as the imbibition of the dissolution medium 391 
in the compact also strongly depends on the surface properties, in particular the surface energy 392 
(wettability) of the material.  393 
A slightly different application of mercury porosimetry in pharmaceutical technology was demonstrated 394 
by Guerin et al., 1999. They proposed that the mercury intrusion of a powder bed causes a rearrangement 395 
of the particles, and, therefore, the intruded volume at low pressures can be used to analyse 396 
compressibility and flow properties of pharmaceutical powders. Seven different pharmaceutical powders 397 
were analysed and the results revealed that the compressible volume determined by mercury 398 
porosimetry is in excellent agreement with the compressible volume determined using a powder tester 399 
apparatus. The bulk modulus  of the skeletal material making up the solid phase of the porous medium (a 400 
measure of the ability of the sample solid phase to withstand changes in volume when under 401 
compression) of MCC/indomethacin tablets was studied by Ridgway et al., 2017. The authors prepared 402 
tablets with varying API concentrations and porosities and measured the bulk modulus of the material 403 
making up the pore walls of these different sets of tablets. The measurements revealing the bulk modulus 404 
were performed by analysing the change of apparent intruded volume at intrusion and extrusion of 405 
mercury at the highest pressures. A typical pore retention hysteresis over the pressure range largely below 406 
the maximum pressure region could be observed, which indicated that the skeletal material is partially 407 
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undergoing plastic deformation during the pore volume measurement. At the highest pressures, however, 408 
the mercury volume at extrusion could be seen to equal that of intrusion as a function of pressure, such 409 
that the skeletal material was considered to have been elastically compressed. Here the gradient of the 410 
elastic response to pressure provides a measure of the elastic bulk modulus of the skeletal material, Figure 411 
10. Ridgway et al., 2017, demonstrated that the bulk modulus of the skeletal material increased with 412 
porosity associated with increasing API loading.  413 
The determination of elastic bulk modulus of the skeletal material occurring during the porosimetry 414 
measurement, as described above, can be undertaken, based on the model proposed by Gane et al., 1996, 415 
embedded as part of a pore modelling software program package (PoreXpert software available from the 416 
University of Plymouth, Plymouth, UK) that can also simulate the pore structure of the sample measured. 417 
The concept of the model is to overcome one of the major limitations to any analysis of mercury intrusion 418 
data, i.e. only being able to describe the pore structure as a bundle of parallel capillary tubes 419 
corresponding to the range of intruded capillary diameters, which in turn correspond to the pressure 420 
range applied. The experimenter must, therefore, resort to such models to advance an understanding of 421 
the differences between pore size, connectivity and structure tortuosity. Furthermore, the intrusion 422 
method is susceptible to pore shielding, in which access to a large diameter pore is restricted by a narrow 423 
entry throat, such that the volume intruded into the large pore is erroneously recorded as intrusion into 424 
a pore having the diameter of the narrow throat.  425 
Use of the model, described above, showed the rate of absorption is dependent on many aspects of the 426 
geometry of the void structure as well as on the properties of the fluids. The results confirmed that 427 
realistic absorption dynamics cannot be modelled using the Lucas-Washburn equilibrium between 428 
Poiseuille flow resistance and capillary wetting force alone. Rather, the absorption rate as a function of 429 
time depends upon pore size distribution, connectivity and connecting throat length, together with fluid 430 
properties including viscosity and density (Ridgway and Gane, 2002). The Bosanquet model can be used, 431 
including an inertial acceleration related term complementing the Lucas-Washburn viscous description 432 
(Bosanquet, 1923). It could be shown that short timescale acceleration and deceleration of fluid, within 433 
the pore structure, leads to plug flow behaviour which deviates from the laminar permeability 434 
approximation. The result is that absorption follows two regimes, inertial plug flow where the rate is 435 
proportional to time, and viscous where the rate is proportional to the square root of time (Bosanquet, 436 
1923; Schoelkopf et al., 2002). 437 
In specifically designed, discretely separable bimodal (dual) porosity structures, porous particles are 438 
compacted together to provide very high absorption rates. In these structures it is possible to separate 439 
the permeability, associated with the interparticle pores, and the capillarity, associated with the 440 
intraparticle pores, with respect to the inflection point of the bimodal cumulative mercury intrusion curve 441 
(Ridgway et al., 2006). Such structures are used across a wide range of industries, but in the context of 442 
this review, they constitute the material termed FCC. This material has been demonstrated primarily as a 443 
functional excipient for orally dispersible tablets (Stirnimann et al., 2014; 2013; Wagner-Hattler et al., 444 
2017). 445 
 446 
 447 
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Table 2: Some applications of mercury porosimetry in pharmaceutical research. HPC: hydroxypropylcellulose; MgSt: magnesium stearate; PVP: polyvinyl 448 
pyrrolidone. 449 
Author Date Measuring apparatus Material Application 
(Strickland et al., 1956) 1956 Custom-built Glass beads, potassium bromide crystals, 
sulfathiazole/starch granules, 
phenobarbital/starch granules, sodium 
bicarbonate/starch granules, aspirin 
granules 
Intragranular porosity 
(Reich, 1967) 
(Reich and Gstirner, 
1968) 
1967 
1968 
Custom-built Starch tablets Pore volume and pore size distribution, 
porosity 
(Selkirk and Ganderton, 
1970a) 
1970 Micromeritics Porosimeter 
Model 905-1 
Tablets containing lactose/sucrose 
granules 
Pore size distribution, porosity 
(Selkirk and Ganderton, 
1970b) 
1970 Micromeritics Porosimeter 
Model 905-1 
Tablets containing lactose granules Pore size distribution, porosity 
(Ganderton and Hunter, 
1971) 
1971 Custom-built from 
(Strickland et al., 1956) 
Lactose and calcium phosphate granules Intra- and extragranular porosity as well as 
total porosity 
(Selkirk, 1974) 1974 Micromeritics Porosimeter 
Model 905-1 
Tablets containing lactose granules Pore size distribution, porosity 
(Marshall and Sixsmith, 
1974) 
1974 Micromeritics Porosimeter 
Model 905-1 
MCC powder Pore size distribution, porosity 
(Palmer and R. C. Rowe, 
1974) 
1974 Micromeritics Porosimeter 
Model 905-2 
Polyvinylchloride powder, glass beads Intra- and interparticle porosities, powder 
packing 
(Sixsmith, 1977) 1976 Micromeritics Porosimeter 
Model 905-1 
MCC tablets Interparticle pore size distribution, porosity 
(Stanley Wood and 
Shubair, 1979) 
1979 Micromeritics Porosimeter 
Model 905-1 
Dicalcium phosphate dehydrate/starch 
granules 
Pore volume and pore size distribution, 
porosity 
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(Dees, 1980) 1980 Custom-built Lactose and sulphadimidine tablets  Pore size distribution, porosity 
(Carli and Motta, 1984) 1982 Macropore Unit Lactose, MCC, indoprofen, and MgSt 
powder 
Particle size and surface area distribution, 
porosity 
(Wikberg and Alderborn, 
1990) 
1990 Custom-built from 
(Strickland et al., 1956) 
Lactose granules Intragranular porosity 
(Wikberg and Alderborn, 
1992) 
1992 Micromeritics Pore Sizer 
9310 
Lactose granule tablets Pore size distribution, porosity 
(Johansson et al., 1995) 1995 Micromeritics Pore Sizer 
9310 
MCC pellets and MCC/salicylic acid Intragranular pore size distribution, 
porosity 
(Juppo, 1996) 1996 Quantachrome Autoscan 
33 Porosimeter 
Lactose, glucose and mannitol granule 
tablets 
Tablet porosity, pore size distribution 
(Juppo et al., 1997) 1997 Quantachrome Autoscan 
33 Porosimeter 
Propranolol hydrochloride/MCC extrudates 
and pellets (extrusion + spheronisation) 
Extrudate and pellet porosity, pore size 
distribution 
(Ridgway et al., 1997) 1997 Micromeritics AutoPore III Lactose/anti-inflammatory compound Pore size distribution, porosity 
(Westermarck et al., 
1998a) 
(Westermarck et al., 
1999) 
(Westermarck et al., 
1998b) 
1998, 
1999 
Quantachrome Autoscan 
33 Porosimeter  
Mannitol, MCC powder; mannitol, MCC 
granules; mannitol powder, MCC powder 
tablets; mannitol granule, MCC granule 
tablets 
Pore size distribution, porosity 
(Riippi et al., 1998) 1998 Quantachrome Autoscan 
33 Porosimeter 
Erythromycin acistrate granules/MgSt 
tablets 
Pore size distribution 
(Vertommen et al., 1998) 1998 Quantachrome Autoscan 
60 Porosimeter 
Pellets of !-lactose monohydrate, MCC and 
riboflabin 
Pore size distribution of meso- and 
macropores 
(Guerin et al., 1999) 1999 Micromeritics Autopore 
9220 Porosimeter  
Dicalcium phosphate, Di TabÒ, Lactose Fast 
FloÒ, Lactose Extra Fine KristalÒ, Lactose 
Compressible volume, powder packing 
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Fine KristalÒ, KetoprofenÒ, Acebutolol 
ChlorhydrateÒ, Celiprolol ChlorhydrateÒ 
powders 
(Mattsson, 2001) 2001 Micromeritics AutoPore III Sodium bicarbonate, sodium chloride, PEG 
3000, PEG 20000, and pregelatinised starch 
(PGS) powders; tablets containing different 
mixtures of these constituents 
Inter- and interparticulate pore size 
distribution 
(Gabaude et al., 2001) 2001 Micromeritics AutoPore III MCC, starch, Pharmatose, and different 
drug powders,  
Pore size distribution, powder packing,  
(Ferrero and Jiménez-
Castellanos, 2002) 
2002 Quantachrome Autoscan 
33 
Tablets of different copolymers. The 
copolymers were synthesised by free 
radical copolymerisation of methyl 
methacrylate and different carbohydrates 
(hydroxypropylstarch, 
carboxymethylstarch, 
hydroxypropylcellulose) 
Total porosity and pore size distribution 
(Freitag et al., 2004) 2004 Micromeritics Poresizer 
9320 
Magnesium carbonate powder and 
granules; magnesium carbonate 
granule\MgSt tablets 
Pore size distribution, tablet porosity 
(Ohno et al., 2007) 2007 Micromeritics Autopore 
9420 
Mefenamic acid, lactose monohydrate, 
low-substituted HPC, MCC, HPC and MgSt 
granules 
Porosity, intragranular pore size 
distribution, effect of average pore 
diameter on dissolution. Effect of granule 
process parameters on porosity and 
average diameters 
(Crean et al., 2010) 2010 Micromeritics AutoPore IV 
9500 
!-lactose monohydrate granules with PVP Intragranular porosity and pore size 
distribution 
(Krupa et al., 2012) 2012 Quantachrome 
PoreMaster 60 
Pure F-Melt tablets; tablets containing of F-
Melt and one of the three APIs: ibuprofen, 
Porosity and pore size distribution (related 
to disintegration time) 
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diclofenac sodium or diltiazem 
hydrochloride 
(Schrank et al., 2012) 2012 Quantachrome Poremaster 
60-GT 
Calcium stearate/ibuprofen pellets Porosity and average pore size 
(Sprunk et al., 2013) 2013 Thermo Fisher  PASCAL 140 Indomethacin/sodium dodecyl 
sulfate/maltodextrin dry foams 
Pore size distribution 
(Stirnimann et al., 2014) 2014 Micromeritics Autopore V Compaction structure of functionalised 
calcium carbonate 
Discretely bimodal pore size distribution 
(Preisig et al., 2014) 2014 Micromeritics Autopore V Drug loading into porous calcium 
carbonate by solvent evaporation 
Pore space occupied by API 
(Ridgway et al., 2017) 2017 Micromeritics Autopore V  Indomethacin/MCC tablets Porosity, pore size distribution and bulk 
modulus 
(Markl et al., 2017b) 2017 Micromeritics Autopore V Functionalised calcium carbonate Pore size distribution 
450 
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5. Nuclear	Magnetic	Resonance	451 
NMR is a non-invasive and chemically specific technique that can be applied to study mass transport 452 
phenomena quantitatively in the form of molecular diffusion and flow (Mantle, 2013). The complete 453 
theory of NMR is beyond the scope of this review article and the reader is referred to several excellent 454 
books (Brown et al., 2014; Callaghan, 1993; Levitt, 2008).  455 
Basically, an NMR signal is generated when a nucleus of non-zero spin is subjected to a strong magnetic 456 
field and radio-wave irradiation. Since the nucleus has a net magnetic moment, it tends to align with the 457 
applied magnetic field. This results in a net magnetisation vector aligned parallel to the direction of the 458 
magnetic field, which precesses when disturbed from equilibrium by exposing the system to radio-459 
frequency (RF) radiation. This precession induces a voltage in the surrounding tuned coil, which represents 460 
the NMR signal. The frequency of the precession is the so-called Larmor resonance frequency and it is 461 
equal to the product of the applied magnetic field and the gyromagnetic ratio. The gyromagnetic ratio is 462 
an isotope-specific property that is largest for the hydrogen nucleus. Typically, a pulse of RF radiation at 463 
the Larmor resonance frequency of the nucleus of interest is used to disturb the nuclei from equilibrium 464 
and to set them into precession. The NMR signal is inherently weak, but it increases in strength with an 465 
increasing gyromagnetic ratio and applied magnetic field.  466 
NMR and the closely related magnetic resonance imaging (MRI) technique have been applied to study the 467 
fundamental processes involved in the disintegration (Quodbach et al., 2014a; 2014b; Tritt-Goc and 468 
Kowalczuk, 2002) and dissolution (C. Chen et al., 2014; Y. Y. Chen et al., 2010; Mantle, 2016; 2013; 2011; 469 
Melia et al., 1998; Nott, 2010; Richardson et al., 2005; Tajarobi et al., 2009; Zeitler and Gladden, 2009; 470 
Zhang et al., 2011) of solid dosage forms. The characterisation of pore structures using NMR is typically 471 
performed by measuring the signal from liquids interacting with the solid material as the relaxation times 472 
of the solid phase are too short to be measured by NMR. There are three main approaches in NMR to 473 
gather information about the pore structure of porous samples: NMR cryoporometry, diffusometry and 474 
relaxometry. Each of these will be discussed in the following.  475 
NMR cryoporometry is a thermoporometry technique, which is suitable for mapping the pore size 476 
distribution of a material (Strange et al., 1996). The sample is saturated with a suitable liquid (typically 477 
water or cyclohexane) and the porous sample is cooled until all liquid is frozen. The sample is then 478 
gradually warmed up causing the melting of the water or cyclohexane crystals that were formed in the 479 
pores. In their frozen state the molecules of the liquid used to fill the pores do not result in an NMR signal 480 
due to the fast relaxation in solids. The crystals within the small pores will melt before those from larger 481 
pores and the volume of the liquid produced yields an NMR signal that is proportional to the volume of 482 
pores smaller than a specific size, !. The crystals of dimension ! melt at a temperature ", which is lower 483 
than the bulk material melting point "#. The Gibbs-Thompson equation, Δ"(!) = (/!, is utilised to relate 484 
the melting point change, Δ"(!) = "# − ", for liquids in pores and their respective pore size. The melting 485 
point depression constant ( depends on the properties of the liquid and the liquid/solid interface. 486 
Consequently, ( needs to be determined for the probe material using samples with known pore size 487 
distribution (Strange et al., 2003). Similar measurements can be performed with differential scanning 488 
calorimetry (DSC) or differential scanning microscopy, which results in an experimental graph of heat flow 489 
and temperature that can be related to a pore size distribution (Rouquerolt et al., 1994). DSC measures 490 
the actual melting manifested by heat transfer, whereas NMR cryoporometry determines the fraction of 491 
liquid molten at a range of temperatures.  492 
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Diffusometry provides a measure relating to the surface-to-volume ratio and the tortuosity of the pore 493 
structure by determining the time-dependent diffusion coefficient, +(,), of a liquid diffusing in the pore 494 
space of a material (Collins et al., 2007). The analysis of the +(,) at short observation times provides the 495 
surface-to-volume ratio, while the +(,) at long observation time yields the tortuosity of the pore 496 
structure.  497 
Another NMR-based approach is relaxometry, which exploits the enhanced relaxation of molecules at a 498 
pore surface to determine the pore size. By assuming a rapid exchange between molecules at the surface 499 
and in the pores, the inverse spin-lattice and spin-spin relaxation rates are then proportional to the 500 
surface-to-volume ratio of the pore structure (Strange et al., 2003). The pore size distribution can be 501 
calculated by combining the measured relaxation times with an estimated mean surface relaxivity of the 502 
material. This relaxivity is assumed to be constant throughout the sample and it can be calculated by 503 
matching the relaxation times with pore size distributions determined by mercury porosimetery or 504 
nitrogen adsorption (Collins et al., 2007). Relaxometry was also combined with cryoporometry by 505 
measuring the relaxation times throughout the melting of the sample (Valckenborg et al., 2002). The setup 506 
of this combined approach is illustrated in Figure 11. 507 
The majority of applications employing NMR methods to characterise pore structures are in fields outside 508 
pharmaceutical sciences. NMR cryoporometry was demonstrated for studying the pore structure of silica 509 
gels, bones, cements, rocks and many other applications (Allen et al., 1998; Alnaimi et al., 1994; Mitchell 510 
et al., 2008; Strange et al., 2003; 1996; 1993). The pharmaceutical applications of NMR are summarised 511 
in Table 3. 512 
The pore structure of calcium carbonate was studied using NMR cryoporometry by Gane et al., 2004. A 513 
very similar material, namely FCC, has recently found its application in the pharmaceutical field, where it 514 
is of particular interest for orally disintegrating tablets (Stirnimann et al., 2014; 2013; Wagner-Hattler et 515 
al., 2017) due to its very high intraparticulate porosity. Gane et al., 2004 studied calcium carbonate tablets 516 
compacted at different compression pressures leading to different total porosities and pore size 517 
distributions as measured by the authors using NMR cryoporometry. Boissier, Feidt and Nordstierna, 2012 518 
applied NMR cryoporometry to measure the pore size distribution of pharmaceutical coatings, which 519 
revealed that the amount of solvent in the coating mixture impacted the connectivity of the pore channels 520 
in the film. The authors proposed that the lack of interconnected channels prevented the complete 521 
removal of the solvent and it therefore affected the permeability of the film. Another pharmaceutical 522 
application of NMR cryoporometry was presented by Petrov et al., 2006. The authors studied the pore 523 
size distribution of biodegradable polymer microparticles, which can be used for drug delivery in depot 524 
formulations (Figure 11b and c). The dry polymer powder was placed in an NMR tube that was filled with 525 
water to study the swelling of the microparticles. NMR cryoporometry measurements were performed 526 
on samples after 1, 3 and 4 days in the water reservoir to study the evolution of the pore size distribution 527 
as the particles swelled and degraded in the aqueous environment. The evolution of the porosity of 528 
controlled drug-release pellets was studied by Collins et al., 2007 using diffusometry and relaxometry 529 
(Figure 12). The partially soluble pharmaceutical pellets (see Table 3 for their composition) were 530 
immersed in water for different lengths of time and the restricted diffusivity of water trapped within the 531 
pellets was measured by NMR. This restricted diffusivity was used to calculate the surface-to-volume ratio 532 
and tortuosity of the pore structure. Furthermore, the authors also measured the relaxation time of the 533 
water trapped within the pellets, which was used to calculate the pore size distribution as a function of 534 
immersion time. The pore structure clearly changed as indicated by the decreasing surface-to-volume 535 
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ratio and the tortuosity as well as the increasing mean and modal pore sizes with increasing immersion 536 
time. NMR relaxometry was also used by Nebgen et al., 1995 to characterise the pore structure of MCC 537 
tablets. The pores were filled with silicon oil to overcome the low signal intensity from the solid material 538 
and to reveal the inner structure of the tablet. This procedure enabled the analysis of the distribution of 539 
open voids that were filled with silicone oil. 540 
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Table 3: A selection of applications of NMR in the pharmaceutical field. HPC: hydroxypropylcellulose; EC: ethylcellulose. 541 
Author Date Principle Materials Probe liquid Application 
(Nebgen et al., 1995) 1995 Relaxometry Pure MCC tablets Silicone oil Cross-section images of pore 
structures within the tablets; 
porosity distributions 
(Gane et al., 2004) 2004 Cryoporometry Calcium carbonate tablets (related to the 
functionalised calcium carbonate as a 
pharmaceutical excipient) 
Cyclohexane Pore size distribution 
(Petrov et al., 2006) 2006 Cryoporometry Porous biodegradable polymer microparticles  Water Pore size distribution 
(Collins et al., 2007) 2007 Diffusometry and 
relaxometry 
Drug-loaded pellets containing chlorpheniramine 
maleate (API), lactose, MCC and glycerol 
monostearate; placebo pellets consisting of the 
same formulation as above except for the API 
Water Surface area/volume ratio, 
tortuosity and pore radius as 
functions of immersion time; 
pore size distribution 
(Boissier et al., 2012) 2012 Cryoporometry Coatings composed of HPC and EC Octamethyl-
cyclotetra- 
siloxane and 
water 
 
Pore size distribution of the EC 
films (HPC was evaporated 
prior to the NMR 
measurement) 
 542 
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6. X-ray	Computed	Microtomography  543 
There are four fundamental steps to capture porosity using XµCT (Figure 13). Firstly, data acquisition in 544 
the XµCT device, which uses polychromatic X-rays to scan an object and obtain vertical projections from 545 
different angles around the sample. The attenuation of the X-rays through the object is linked to its 546 
absorption coefficient by the Beer-Lambert law and hence its density, which is represented as a grey scale 547 
image (Zeitler and Gladden, 2009). There are different possible configurations for the XµCT, notably the 548 
cone-beam configuration with a 2D array detector (Figure 14), which is most commonly used. Other set-549 
ups include the plane-parallel and the first generation single beam configuration (Zeitler and Gladden, 550 
2009).  551 
The second step is data reconstruction: the acquired 2D XµCT vertical images are computationally 552 
reconstructed to create 2D horizontal slices using the Feldkamp algorithm, which are stacked to create a 553 
3D volume. Higher XµCT resolution results in finer details, but requires additional processing memory and 554 
storage space. A key benefit of XµCT is its non-destructive nature and that it does not require much sample 555 
preparation. Drawbacks include both lengthy measurements and image processing. Likewise, a small 556 
sample size is needed to avoid beam hardening, which occurs when the sample centre receives more 557 
exposure from high energy X-ray beams. Low energy X-ray beams are more easily absorbed and hence X-558 
ray attenuation for the benchtop polychromatic sources is not linear with density across the X-ray 559 
spectrum (Ho and Hutmacher, 2006). As with any imaging technique, pores smaller than the XµCT 560 
resolution are not detected. The third step of XµCT for porosity is image analysis: the 3D images must be 561 
segmented to differentiate pores from solid material, such that the pore parameters can be calculated. 562 
Finally, in the fourth step the calculated pore parameters need to be analysed, processed and usually 563 
presented graphically (see section 2). Depending on the raw data, the image might need to be cropped 564 
into a smaller subvolume, to enable the computer to process the data in a reasonable time frame. Since 565 
the spatial resolution is typically inversely proportional to the field of view (in particular for a cone-beam 566 
configuration), the acquired image size may be restricted to a subvolume of the entire dosage form given 567 
the high spatial resolution required to access pharmaceutically relevant pore characteristics. 568 
Consequently, the measurement results will depend on the spatial resolution as well as whether or not 569 
the selected subvolume is representative of the overall dosage form (Rouquerolt et al., 1994). 570 
There are six main types of image segmentation techniques: histogram shape based, entropy based, 571 
spatial, clustering, object attribute and local methods (Sheikhveisi, 2015). Iassonov et al., 2009 lament 572 
that despite recent advances in computed tomography technology, image segmentation technology lags 573 
behind. They criticise that many papers present binarised pore representations without explaining their 574 
image processing method. The most common approach is global thresholding: the image intensity 575 
histogram is split by a single cut-off value. A substantial review of different publications and their pore 576 
image segmentation was undertaken to identify the best processing method, with summarised findings 577 
in Table 4. 578 
Specific challenges in image processing include the potentially large errors that are the result of 579 
performing the analysis on individual cross-sectional slices in 2D rather than 3D analysis, which creates 580 
directional bias and ignores geometrical information from planes directly above or below each 2D slice 581 
(Iassonov et al., 2009; Kaestner et al., 2008). Another image processing artefact is the partial volume 582 
effect, where features smaller than one voxel become upscaled to one voxel (Pak et al., 2016). An XµCT-583 
specific image processing problem are real ring artefacts, due to detector drift, and quasi-ring artefacts, 584 
due to inconsistent X-ray beam intensity (Antoine et al., 2002). Kaestner et al., 2008, note the importance 585 
of removing these before further processing. Additionally, if pore sizes span several orders of magnitude, 586 
images at different XµCT resolutions need to be combined to create accurate, multi-scale pore network 587 
models (Pak et al., 2016).588 
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Table 4: Summary of some XµCT applications for the characterisation of porous materials. Information not given is indicated with ‘N/A’. The references above 589 
and below the double line are related to applications across various different fields versus applications on solely pharmaceutical materials, respectively. 590 
Author  Date Measuring technique Material Processing method Software 
(Antoine et al., 2002) 2002 
Beamline ID22 of 
the European 
Synchrotron 
Radiation Facility  
Paper Low pass filtering and region growing algorithm N/A 
(Iassonov et al., 2009) 2009 
Industrial HYTEC 
Flat Panel 
Amorphous Silicon 
High-Resolution 
Computed 
Tomography 
(FLASHCTTM) 
system 
Macro- porous soils, 
sand-bentonite 
mixtures, and precision 
glass beads 
Compared performance of 14 algorithms: Otsu 
and Ridler clustered global-thresholded best, as 
well as locally adaptive thresholded 
Custom (MATLABTM 
and C++) 
(Tolnai et al., 2009) 2009 
Beamline ID19 of 
the European 
Synchrotron 
Radiation Facility 
Al alloy  Binary thresholding and region growing algorithm, identifying volumes of three different phases 
Tomo 3D (Eötvös  
Loránd University) 
(Yang et al., 2014) 2010 
SOMATOM 
Sensation 
16 (medical CT 
scanner) 
Copper sulphide ores Otsu thresholding method Custom (MATLABTM) 
(Fusseis et al., 2012) 2012 
Synchrotron 
bending magnet 
beam line 2-BM at 
the Advanced 
Photon Source  
Dehydrated 
polycrystalline gypsum Binary thresholding 
Commercial (Avizo 
Fire) 
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(Reh et al., 2012) 2012 
X-ray nanotom XCT 
system (GE 
Phoenix) 
Carbon fibre reinforced 
polymers 
Anisotropic diffusion filter then Otsu’s 
thresholding algorithm 
Custom built 
(iAnalyse) 
(Korat et al., 2013) 2013 Xradia 400 Fired silica sludge/fly ash foams 
Hysteresis thresholding, then filling holes function 
and watershed algorithm 
Commercial (Avizo 
Fire) 
(Jie Liu et al., 2014) 2014 N/A Heterogeneous carbonates Indicator Kriging segmentation algorithm N/A 
(Suresh and Neethirajan, 
2015) 2015 
Bruker SkyScan 
1172 Wheat kernels Multithresholding techniques 
Commercial (Avizo 
Fire) 
(Claes et al., 2016) 2016 Siemens Somatom scanner 
Carbonate reservoir 
rocks 
Dual-thresholding hysteresis algorithm, then 
watershed N/A 
(Pak et al., 2016) 2016 
μCT instrument 
built in-house at 
the University of 
Edinburgh 
Heterogeneous 
carbonate rocks 
Anisotropic diffusion filter and watershed 
algorithm 
Commercial (Avizo 
Fire, v8) 
(Schmitt et al., 2016) 2016 
Nanotom 180S 
instrument (GE 
Sensing & Inspec- 
tion Technologies) 
German sandstone 
rocks Watershed algorithm  
Commercial (Avizo 
Fire, v9.01) 
(Farber et al., 2003) 2003 SkyScan 1072 XRCT 
MCC granules with 
either mannitol or 
lactose  
N/A 
Commercial 
(Skyscan software 
package and Image-
Pro) 
(Sinka et al., 2004) 2004 Tomohawk CT by AEA Technology 
Density distribution in 
MCC tablets 
No image binarisation needed as X-ray attenuation 
is linearly related to density 
Commercial 
(Tomohawk CT 
software) 
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(Busignies et al., 2006) 2006 SkyScan 1072 XRCT 
Density profile of MCC 
compacts with ranging 
porosities 
Median filter to reduce noise, then greyscale 
replaced with colour scale and normalisation to 
increase contrast 
Commercial 
(ImageJ) 
(Ansari and Stepanek, 2006) 2006 SkyScan 1072 XRCT 
D-mannitol with poly-
ethylene glycol (PEG-
6000) granules 
Image enhancement by thresholding, de-
speckling, filling holes, dilating, eroding and again 
filling holes if necessary 
Commercial 
(ImageJ) 
(Ansari and Stepanek, 2008) 2008 SkyScan 1072HR 
Mannitol with 
polyethylene glycol 
granules and sucrose 
with poly-vinyl 
pyrrolidone 
Image filtering and segmentation N/A 
(Young et al., 2008) 2008 Bruker SkyScan 1172 
Inert matrix tablets 
(ferrous sulphate, 
lactose and Eudragit) 
Gaussian filter for background noise and then 
segmentation tool 
Commercial 
(Volume Graphics 
Studio Max) 
(Rahmanian et al., 2009) 2009 
Nanotom XMT by 
Phoenix X-ray 
Company 
Calcium carbonate and 
polyethylene glycol 
granules made in a high 
shear granulator 
N/A 
Commercial (VG 
Studio max 
software) and 
Custom (Fortran) 
(Crean et al., 2010) 2010 Bruker SkyScan 1172 
!-lactose monohydrate 
granules with polyvinyl 
pyrrolidone 
Thresholding, pore and binder domains were 
measured using a structure thickness distribution  
Commercial 
(SkyScan CTAn) 
(Akseli et al., 2011) 2011 Bruker SkyScan 1172 
Roller-compacted 
ribbons 
Thresholding used to remove beam-hardening 
artefacts, then statistical methods to relate 
average grayscale value to relative density of 
material 
ImageJ and Custom 
(MATLABTM) 
(Sprunk et al., 2013) 2013 Bruker SkyScan 1172 
Indomethacin/sodium 
dodecyl 
sulfate/maltodextrin 
dry foams 
No data processing, only visualisation Commercial (SkyScan CTVox) 
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(Wong et al., 2014) 2014 Xradia NanoXCT-100 
raw (2-hydroxypropyl)-
beta-cyclodextrin, poly 
(lactic-co-glycolic) acid 
microparticles, and 
spray-dried particles 
that included smooth 
and nanomatrix bovine 
serum albumin, lipid-
based carriers, and 
mannitol 
Pore volumes, pore size distributions, and 
porosity of individual mannitol particles and 
single PLGA particles were obtained using 
watershed-based segmentation and thresholding 
limits to differentiate between the material and 
pores  
Commercial (Avizo 
Fire) 
(Robert et al., 2016) 2016 Nikon Metrology X-Tek HMXST225 
Porous polydimethylsi-
loxane block for drug 
delivery 
N/A 
Commercial 
(Volume Graphics 
Studio Max) 
(Dennison et al., 2016) 2016 Bruker SkyScan 1172 
Different droplet sizes 
of Kollicoat IR coating 
on model tablet 
Two methods: Bruker-MicroCT CT-Analyser 
porosity plugin for 5 farther z slices and ImageJ 
Huang threshold and binarisation, with a ROI 
chosen to measure porous area fraction 
Bruker-MicroCT  CT-
Analyser and ImageJ 
(Markl et al., 2017b) 2017 Bruker SkyScan 1172 
Functionalised calcium 
carbonate tablets Watershed algorithm 
Commercial (Avizo 
Fire) 
(Markl et al., 2017c) 2017 Bruker SkyScan 1172 
3D printed 
compartmental dosage 
forms made of 
polyvinyl alcohol and 
polylactic acid filaments 
Watershed algorithm Commercial (Avizo Fire) 
(Alhijjaj et al., 2017) 2017 Bruker SkyScan 1172 
Phase separation 
behaviour of solid 
dispersions with 
felodipine 
Thresholding into binary images Commercial (CTan and CTvol) 
591 
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The final stage is quantifying the image processing error – which is infrequently done in the literature. 592 
Chityala et al., 2013 applied different segmentation algorithms to the same dataset and compared their 593 
performances. Fusseis et al., 2012 used another approach, dilating and shrinking the pore data set by ± 1 594 
voxels, their estimated error, and then calculating error bounds of pore parameters. Schmitt et al., 2016 595 
calculated the same parameters with different subvolume sizes to evaluate how representative each 596 
subvolume is of the whole sample. Error from noise can be quantified by segmenting the image with and 597 
without a denoising filter and calculating the number of voxels whose classification (pore or solid) has 598 
changed (Iassonov et al., 2009).  599 
XµCT is helpful in pharmaceutical applications to capture both the open and closed porosity, for both 600 
finished tablets and intermediate materials (e.g. granules). The first use of XµCT in this field dates back to 601 
1999. Since then improvements in resolution have been achieved. A large challenge is thresholding the 602 
acquired images, as contrast in the form of density (greyscale) differences between tablet excipient and 603 
pores is not always clear-cut. Impregnation of the porous samples with labelling solutions, such as lead 604 
containing solutions, can help to increase contrast. Furthermore, XµCT has also been used in situ to track 605 
the development of voids in a tablet during dissolution (Karakosta et al., 2006). One compromise that 606 
needs to be reached is achieving both high resolution and a large field of view with the XµCT, as both are 607 
critical to understand tablet microstructure (Takeda and Hamada, 2014). The large benefit of XµCT as an 608 
imaging method for measuring porosity is the ability to visualise pore networks and calculate pore specific 609 
parameters as detailed in section 2. Markl et al., 2017b took advantage of this to create pore distribution 610 
plots according to the orientation angle ! of each pore (relative to eigenvector "#). Furthermore, results 611 
from the XµCT images can be related to other physical properties, once they are measured with other 612 
techniques. Likewise, specific parts of the tablet can be isolated and inspected further, as they might differ 613 
with respect to pore properties and other parameters. For example, Takeda and Hamada, 2014 isolated 614 
the tablet coating of antihypertensive tablets, with a high resolution nano3DX machine. 615 
The microstructure as elucidated by XµCT can be linked to both physical characteristics such as density, 616 
as well as computer models. This was done by Ansari and Stepanek, 2008 with mannitol-PEG and sucrose-617 
PVP granules. Moreno-Atanasio, Williams and Jia, 2010 performed a review of computer simulations 618 
coupled to XµCT measurements. At a basic level, XµCT can help to validate computer models. Features 619 
such as pore surface area, coordination number and particle shape can be used to relate both approaches. 620 
One area which presents a challenge is the dynamic state relationship between XµCT and computer 621 
simulations (Moreno-Atanasio et al., 2010). XµCT can also be used on its own, without excessive image 622 
processing and hence more uncertainties. In this application, XµCT attenuation is related to sample 623 
density to create tablet density representations. As long as the reference density points for linear 624 
interpolation of the XµCT greyscale are accurate, and an appropriate noise smoothing filter is used, this 625 
method is insightful. Both Busignies et al., 2006 and Sinka et al., 2004, used this approach to understand 626 
tablet compaction behaviour.  627 
7. Terahertz	Time-Domain	Spectroscopy  628 
7.1 Measurement	of	Total	Porosity	629 
Terahertz radiation generally refers to the electromagnetic radiation in the frequency range of 0.1—4 THz. 630 
Advancements in femtosecond lasers have enabled the coherent generation and detection of terahertz 631 
radiation, which have made it possible to readily perform terahertz spectroscopy in a laboratory setting. 632 
Although terahertz imaging and spectroscopy can be performed in a reflection and a transmission setting, 633 
the porosity is typically analysed from terahertz transmission measurements. 634 
In contrast to conventional far-infrared spectroscopy, the terahertz measurements involve the generation 635 
and detection of pulses of terahertz radiation that are transmitted through a tablet. Given that this is a 636 
time-domain technique, both the amplitude and phase changes of the transmitted pulse relative to the 637 
incident pulse are measured. The incident pulse is henceforth referred to as the reference waveform, 638 
which is acquired when no sample is present in the measurement chamber. The phase information is of 639 
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particular importance for determining the porosity from terahertz measurements: the analysis of the 640 
porosity of solid dosage forms is performed by measuring the time delay difference Δ% between the 641 
sample waveform and the reference waveform, i.e. Δ% = '( − '* (Figure 15). In general, Δ% of a terahertz 642 
pulse propagating through a sample depends on the effective refractive index, +eff, as well as the sample 643 
thickness, .. The value of +eff can be readily calculated from the pulse delay time by +eff = Δ% ⋅ 0/. + 	1, 644 
where 0 is the speed of light in vacuum. This straight-forward analysis is based on the time-domain data 645 
and results in a single effective refractive index value per tablet sample. Since the phase and amplitude 646 
of the transmitted terahertz pulse are measured directly, it is furthermore possible to calculate the 647 
frequency-dependent refractive index and absorption coefficient of a sample. The frequency-domain 648 
analysis of the refractive index may provide additional information about the sample, such as specific 649 
phonon vibrations due to a crystalline constituent (e.g. the drug) in the sample (Zeitler, 2016). Such 650 
spectral features cause relatively strong dispersion and the refractive index thus undergoes substantial 651 
changes at the frequencies of these features. It is of great importance for the accuracy of the porosity 652 
calculations that the refractive index is evaluated at the same frequency for measurements of different 653 
samples as well as that it is chosen at a frequency which is not affected by the spectral features, i.e. 654 
spectral regions where the refractive index remains constant with frequency. Figure 16 depicts examples 655 
of effective refractive index values measured for both simple and complex formulations over a range of 656 
excipients. The data clearly indicates that the effective refractive indices are linearly dependent on the 657 
porosity.  658 
When the formulation of a tablet is kept constant, any variations in +eff are exclusively due to changes in 659 
the porosity or density of the sample. This refractive index-porosity relationship can thus be exploited to 660 
calculate the porosity of a solid dosage form from terahertz transmission measurements, either by 661 
establishing a simple linear model, namely the zero porosity approximation (ZPA), or by applying effective 662 
medium theory (EMT) to relate the measured effective refractive index to the porosity of the sample.  663 
7.2 Using	Terahertz	Scattering	to	Determine	Domain	Size	664 
The ZPA and EMT models are defined on the basis of the assumption that scattering of terahertz radiation 665 
from a tablet is negligible. This is a sensible assumption for a large number of cases given the relatively 666 
long wavelength of terahertz radiation (75 µm to 3 mm with maximum intensity at a wavelength of 300 667 
µm). If scattering is present, the frequency-dependent effective refractive index of the tablet can be used 668 
to study the terahertz response with the aid of Kramers-Kronig relations (Silfsten et al., 2011; Tuononen 669 
et al., 2010b). One could, therefore, calculate the porosity based on the effective refractive index of a 670 
tablet, and in a separate analysis use the frequency-dependent optical constants together with Kramers-671 
Kronig analysis to check the presence of scattering, and hence the accuracy of the porosity estimate. 672 
Moreover, the scattering effect has proven useful to measure additional properties of the sample, such 673 
as the ’domain size’ of agglomerated granules in a powder compact. Markl et al., 2017a proposed that 674 
this ‘domain size’ is related to the size of the disintegrated particles. It is thus a descriptor for the 675 
performance of the dissolution process as it reflects changes in the effective surface area of the 676 
disintegrated particles. The authors demonstrated this concept for a complex immediate-release 677 
formulation (M04 in Figure 16), where they showed that a ‘domain size’-related parameter is strongly 678 
correlated to the amount of API dissolved after 20 min (56 = 0.96). In the specific example, the tablets 679 
were all fully disintegrated at 15 min and the early phase dissolution performance following disintegration 680 
is driven by the size of the resulting particles (i.e. by the effective surface area of the disintegrated 681 
particles). The authors also showed that the disintegration performance (disintegration time and API 682 
dissolved after 15 min) is linearly correlated with +eff. This is perfectly in line with the fact that the 683 
disintegration behaviour of immediate-release tablets is controlled by their porosity/density, which can 684 
be directly related to +eff using the ZPA or EMT models.  685 
7.3 Pore	Shape	Analysis	686 
EMT is a general approach to describe macroscopic properties of composite materials which enables the 687 
definition of averages that are representative of the medium in question (Choy, 2016). One of the most 688 
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common EMTs are the Maxwell-Garnett and the Bruggeman formula (Choy, 2016). Since the Maxwell-689 
Garnett approximation is only valid for samples with a small void space and the Bruggeman theory can be 690 
applied to study media with a wide range of void fractions, the latter formalism is mostly used for 691 
characterising pharmaceutical samples (Bawuah et al., 2014; Markl et al., 2017b). The basic assumption 692 
behind the Bruggeman model is that air voids are embedded in a medium. It is, therefore, possible to 693 
consider pores that are embedded in a solid matrix, which consists of a mixture of different excipient and 694 
API particles. Such a construct resembles a two-phase system and the concepts developed for a simple 695 
formulation (i.e. only one constituent) can be readily applied to multi-component systems. The refractive 696 
index of the matrix (dependent on the API and the excipients) can be estimated from terahertz 697 
measurements of tablets compacted to different porosities. In general, the refractive indices of the API 698 
and the excipients can be determined separately by compressing these into compacts and performing 699 
terahertz transmission measurements.  700 
The traditional Bruggeman formalism assumes a spherical shape of the air inclusions in a porous sample 701 
and it leads to a systematic error if the actual shape of the pores strongly deviates from a sphere. The 702 
interparticle pore space is formed during the compaction and the shape of the pores may depend on the 703 
compression force. This was demonstrated for different sets of pure FCC tablets with porosities ranging 704 
from 45% to 65% (Markl et al., 2017b). The authors showed that the interparticle pores of the FCC 705 
compacts are anisotropic in shape and highly aligned. Using an anisotropic Bruggeman model, it was 706 
possible to establish that the pores are needle-like in shape and oriented perpendicular to the compaction 707 
direction. The porosity determined by applying the anisotropic Bruggeman model yielded a very high 708 
correlation coefficient (56 	= 	0.995) with the porosity calculated from the measured true density (using 709 
helium pycnometry) and the bulk density of the tablets (Figure 17).  710 
7.4 Anisotropy	of	Pore	Structure	711 
Building on the well-established mathematical formulae of EMTs and optical-mechanical models (Table 712 
4), the Wiener bounds provide an estimate of the upper and lower limits of the effective refractive index 713 
if there is no information about the shape of the pores and solid particles. For the special case of spherical 714 
pores and solid particles, more stringent limits can be found with the aid of Hashin-Shtrikman bounds, 715 
which are, however, only valid for two-phase systems. Both bounds are based on a priori knowledge of 716 
the refractive index of the constituents. These can be estimated using the concept of ZPA, which involves 717 
the use of a linear extrapolation approach on the obtained effective refractive index from the terahertz 718 
measurements.  719 
Based on the Wiener bounds it is possible to quantify the overall degree of anisotropy of a porous 720 
structure. Bawuah et al., 2016a introduced the concept of a structural parameter to describe the 721 
alignment of pores relative to the solid material in a tablet. This < parameter is capable to reflect 722 
differences in the pore structure for samples of the same overall porosity. This concept was developed 723 
further in order to characterise structural changes of samples of varying porosities (Markl et al., 2018a). 724 
This <= parameter revealed that material attributes, such as particle size or granule density, strongly 725 
impact the anisotropy of the pore structure. The degree of anisotropy particularly influences the 726 
tortuosity and constrictivity of the structure and eventually the disintegration performance of the tablet 727 
(Markl et al., 2018b).  728 
7.5 Link	to	Mechanical	Properties	729 
The optical compressibility, which can be obtained with the aid of the effective refractive index, is an 730 
example how terahertz measurements can yield characteristic parameters that are related to mechanical 731 
properties of the porous tablet. The name “optical compressibility” is adopted to reflect the use of the 732 
effective refractive index in the calculation of the compressibility. This is in reference to the use of the 733 
relative volume change in response to the applied pressure when calculating the mechanical 734 
compressibility (Chakraborty et al., 2017).  735 
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Besides the compressibility, it is also of high interest for the pharmaceutical industry to non-destructively 736 
characterise other mechanical properties of a tablet, e.g. the accurate estimation of the effective values 737 
of the strain and hence, the Young’s modulus. Several methodologies including ultrasonic techniques have 738 
been used to obtain the effective elastic moduli of pharmaceutical tablets (Akseli and Cetinkaya, 2008; 739 
Akseli et al., 2010; Bassam et al., 1990; Hancock, 2000; Ketolainen et al., 1995; Liu and Cetinkaya, 2010; 740 
Liu et al., 2011; Porion et al., 2010; Roberts et al., 1991). Since the Young’s modulus has an explicit 741 
dependence on the porosity, Mazel et al., 2012, and Palomäki et al., 2015, have devised an experimental 742 
technique to measure the porosity dependent Young’s modulus of pharmaceutical compacts. In a related 743 
study, Peiponen et al., 2015, have estimated the porosity dependent Young’s modulus according to 744 
Spriggs’ and Mooney’s relations using the measured terahertz time-domain pulse transmitted through 745 
starch acetate tablets. Application of Spriggs law, however, yielded a non-zero Young’s modulus at 100% 746 
porosity, which is physically impossible. This inconsistency was addressed by invoking the Mooney’s 747 
relation. Table 5 presents these “hybrid” optical/mechanical models, i.e. both optical and mechanical 748 
parameters are present, where the constants b and B refer to conventional mechanical properties and 749 
the porosity f is obtained with the aid of the effective refractive index of the tablet. Now, based on the 750 
definition of the optical compressibility, in this review article, we propose a pure optical version of Spriggs’ 751 
law that can be put into an interesting form as follows: >(@) = >BCDEFGDHTHz(L)HTHz(M)N, where the exponent 752 
consists of a ratio of optical compressibility at zero-porosity, OTHz(0), and at porosity @, OTHz(@), of the 753 
tablet. A similar expression can be derived for an optical Mooney’s relation. Moreover, the terahertz 754 
measurements can also be used to non-destructively and non-invasively predict the conventional strain 755 
of pharmaceutical tablets (Bawuah et al., 2016c). This optical strain concept is capable of providing fast 756 
predictions of the mechanical integrity of tablets.  757 
The properties and models in Table 5 were developed for and applied to terahertz transmission 758 
measurements. However, for industrial implementations and imaging applications it could be preferable 759 
to perform terahertz measurements in a reflection setting (Zeitler et al., 2007). Besides this spatially-760 
resolved information, the terahertz reflection signal can also be utilised to extract the effective refractive 761 
index (Jepsen et al., 2007), which can in turn be used to predict pore structural and mechanical properties 762 
(Table 5) in the same manner as for terahertz transmission measurements. The determination of the 763 
refractive index from reflection data is, however, much more prone to errors, which limits the accuracy 764 
of these measurements (X. Chen et al., 2017). However, reflection measurements can provide additional 765 
information about the surface roughness of a pharmaceutical solid dosage form. The amplitude of the 766 
reflected terahertz pulse of a solid sample is correlated to the surface roughness (Dikmelik et al., 2006; 767 
Jagannathan et al., 2009; Mou et al., 2017), which has been demonstrated for different pharmaceutical 768 
materials (Chakraborty et al., 2016; Markl et al., 2017b). 769 
 770 
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Table 5: Summary of various properties of porous pharmaceutical tablets calculated from THz-TDS measurements. More details about most of the materials can 771 
be found in the supporting information according to the code in the brackets in the column marked Materials. IM: indomethacin; SA: potato starch acetate; FF: 772 
flat-faced tablet; BC: biconvex tablet; !": intrinsic refractive index of component #; $": mass fraction of component # (the mass fraction is $% = 1 − ) in case of 773 
the two component models); 	,mech: mechanical strain; 1: depolarisation factor. 774 
Property Model Comp-
onents 
Equation Materials Shape Reference 
Porosity Zero porosity 
approximation 
2 ) = !eff − !%1 − !%	  MCC SA (M02) 
MCC 
MCC 
MCC + IM (M03) 
FCC (M01) 
FF  
FF 
BC 
FF 
FF 
FF 
(Ervasti et al., 2012) 
(Peiponen et al., 2015) 
(Bawuah et al., 2016b) 
(Ridgway et al., 2017) 
(Bawuah et al., 2016c) 
(Markl et al., 2017b) 
3 ) = !% − (!% − !4)$4 − !eff!% − 1  MCC + IM (M03) MCC + IM (M03) FF FF (Bawuah et al., 2016c) (Chakraborty et al., 2017) 
Porosity Bruggeman 
model 
2 !%4 − !eff4!eff4 + 2(!%4 − !eff4 ) (1 − )) + 1 − !eff4!eff4 + 2(1 − !eff4 ) ) = 0 ) = 11 − 991 − !:;;4 < 91+ 2!:;;4 <= <99!%4 + 2!:;;4 < 9!%4 − !:;;4 <= < 
 
MCC 
FCC (M01) 
FF 
FF 
(Bawuah et al., 2014) 
(Markl et al., 2017b) 
Anisotropic 
Bruggeman 
model 
2 !%4 − !eff4!eff4 + 1(!%4 − !eff4 ) (1 − )) + 1 − !eff4!eff4 + 1(1 − !eff4 ) ) = 0 ) = 11 − 991 − !:;;4 < 91 + 1	!:;;4 <= <99!%4 + 1	!:;;4 < (!%4 − !eff4 )= < 
FCC (M01) 
Complex 
formulation 
(M04) 
FF 
BC 
(Markl et al., 2017b) 
 
Structural 
parameter 
S parameter J > = 1!?4 + !@4 A!?4!@4!eff4 − !@4B 
with !? and !@ as the upper and lowee Wiener bound. 
MCC 
MCC + IM (M03) 
MCC + IM (M03) 
FF  
FF 
FF 
(Bawuah et al., 2016a) 
(Bawuah et al., 2016a) 
(Chakraborty et al., 2017) 
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FCC (M01) FF (Markl et al., 2017b) 
 Alternative      
S parameter 
J >C = ⎩⎪⎨
⎪⎧0.5 J1 − !@4(!ideal4 − !eff4 )!eff4 (!ideal4 − !L4)P0.5 J1 − !eff4 − !ideal4!?4 − !ideal4 P  
with !? and !@ as the upper and lower Wiener bound.  !ideal is 
calculated using either ZPA or an EMT model with a known 
porosity. 
MCC + IM (M03) 
FCC (M01) 
Complex 
formulation 
(M04) 
FF 
FF 
BC 
(Markl et al., 2018a). 
Bounds Wiener 
bounds 
J !? = Q) +R$S	!S4		TSU%  !@ = 1V) +∑ $S!S4			TSU%  
MCC + IM (M03) 
SA (M02) 
 
  
FF 
FF 
  
(Bawuah et al., 2016a) 
(Tuononen et al., 2010a) 
Hashin–
Shtrikman  
2 !? = Q!%4 + )11 − !%4 + 1 − )3!%4  
!@ = Q1 + 1 − )1!%4 − 1 + )3 
MCC 
SA (M02) 
FF 
FF 
(Bawuah and Peiponen, 2016) 
(Bawuah and Peiponen, 2016) 
Optical strain  J ,THz = ln ]1 − )1 − )^ _ + ,mech 		 ,`ab = c! ] ΔeΔe^_ = c! J !:;; − 1!:;;,^ − 1P + gh:ij 
MCC + IM (M03) FF (Bawuah et al., 2016c) 
Optical 
compressibility 
 3 kTHz = 1!eff − 1	 MCC + IM (M03) FF (Chakraborty et al., 2017) 
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kTHz = 1(!% − 1)(1 − )) − (!% − !4)$4 
Young’s 
modulus 
Spriggs’ law J lTHz = l^mnop	 lTHz = l^mno]%nqTHz(^)qTHz(p)_ SA (M02( FF (Peiponen et al., 2015) 
Mooney’s 
relation 
J lTHz = l^mnr p%np SA (M02) FF (Peiponen et al., 2015) 
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8. Discussion  776 
The five methods presented in this review vary considerably in terms of speed, accessible information as 777 
well as sample preparation. An overview of the key characteristics of the five methods is provided in Table 778 
6. 779 
Mercury porosimetry and helium pycnometry are well-established methods to determine bulk properties 780 
of a porous sample. The advances in terahertz and X-ray technologies over the last decades provide 781 
scientists with new tools to characterise the microstructure of pharmaceutical solid dosage forms. In 782 
comparison with the other techniques, one of the main advantages of THz-TDS and XµCT are that they 783 
are non-destructive and contactless measurements. This is particularly important when wishing to use 784 
different techniques on the same sample or to perform measurements before and after a treatment of a 785 
sample. The high acquisition rate of THz-TDS is additionally beneficial for quality control as it facilitates 786 
the investigation of several samples within a few seconds. It has, therefore, potential to be applied at-787 
line, on-line or even in-line in a production environment to control dosage form porosity in real-time. This 788 
would particularly impact the realisation of real-time release testing for immediate-release formulations, 789 
where the porosity is one of the most important contributors to the performance of a tablet.  790 
THz-TDS, however, does not yield a pore size distribution and it may be limited by the sample thickness 791 
due to strongly absorbing materials. Even though the determination of the porosity by THz-TDS has been 792 
demonstrated for biconvex tablets with a thickness of up to 5.3 mm (M04 in Figure 16), the penetration 793 
depth may be shorter for tablets containing materials that exhibit a stronger absorption of terahertz 794 
radiation. THz-TDS only provides information on bulk properties and cannot resolve local structural 795 
changes, but this is possible with XµCT. Although X-rays can penetrate typical pharmaceutical materials 796 
easily, the contrast between voids and solid material can be very low. This can cause issues when 797 
processing the images to extract quantitative information as the voids cannot be unambiguously 798 
separated from the solid phase, which can result in erroneous structural parameters. Furthermore, the 799 
spatial resolution of XµCT limits the size of detectable pores and voids smaller than the resolution limit 800 
will be considered as solid material. For a highly-porous sample, a cluster of fine pores (≪ resolution limit) 801 
may be misclassified as one single large pore. This can result in an overestimation of larger pores by XµCT, 802 
which helps explaining discrepancies with results obtained from mercury porosimetry where every single 803 
pore size is registered separately (Markl et al., 2017b). However, the pore shielding effect in mercury 804 
porosimetry may result in an overestimation of fine pores. The nonwetting mercury is forced through fine 805 
pores connecting larger pores (see Figure 9), which results in an overestimation of the small pores and at 806 
the same time an underestimation of the intrusion volume of the large pores (Gane et al., 2004). This 807 
effect impacts the pore size distribution (Farber et al., 2003), but it does not affect the measurement of 808 
the overall porosity of the measured sample. However, a small systematic error in the overall porosity can 809 
be due to a slight compression of the compact before actual intrusion occurs.  810 
Bulk properties from THz-TDS and XµCT may also deviate from those obtained using helium pycnometry 811 
and mercury porosimetry, since these techniques can only access open pores. In the majority of cases 812 
pharmaceutical tablets consist of a highly connected pore structures resulting in a small number of closed 813 
pores and therefore, porosity values from the different techniques are typically in good agreement (Figure 814 
17 and Figure 18). A particularly good correlation can be observed between the porosities calculated from 815 
THz-TDS and helium pycnometry as shown in Figure 17 ("# = 0.995) and in Figure 18b ("# = 1) for FCC 816 
and MCC/indomethacin tablets, respectively. However, helium pycnometry may overestimate true 817 
density values due to the presence of water molecules in the pore space. The calculation of the skeletal 818 
volume is then affected by the release of water during the measurement as it assumes a constant number 819 
of gas molecules (Sun, 2004). As an example, this phenomenon has to be considered when determining 820 
the true density of MCC, as discussed by Sun (Sun, 2005). It has been demonstrated that the walls of the 821 
measurement chamber and the surface of the sample may adsorb and absorb small amounts of helium, 822 
which causes an overestimation of the true density of the porous material (Keller and Staudt, 2006).  823 
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Strange et al., 2003, demonstrated that the pore size distributions from NMR cryoporometry of different 824 
silica samples are in very good agreement with those from gas adsorption and DSC thermoporometry. 825 
Gane et al., 2004, investigated how mercury intrusion porosimetry, NMR-based cryoporometry, and DSC-826 
based thermoporometry compared in revealing the porous characteristics of ground calcium carbonate 827 
structures compacted over a range of pressures. These methods place the samples in nearly the same 828 
mutual order with either very similar cumulative pore volume curves (mercury porosimetry and DSC 829 
thermoporometry) or similar pore size distribution curves, as determined by the change of pore volume 830 
with respect to the change of pore radius by d+/d", (mercury porosimetry and NMR). The pore size 831 
distribution from NMR cryoporometry may be shifted toward smaller pores in cases where air bubbles 832 
are entrapped in larger pores. These air bubbles restrict the liquid from flowing into the larger pores 833 
during the imbibition process and NMR cryoporometry then overestimates smaller pore sizes.  834 
Many studies in the literature present data from different techniques that are in excellent agreement. 835 
However, this might only be valid for a specific material and range of pore sizes. As an example, thermo- 836 
and cryoporometric methods may mask some artefacts for smaller pores as they exhibit larger changes in 837 
melting points (Gane et al., 2004). Moreover, samples may differ in terms of interconnectivity and pore 838 
wall curvature, which particularly influence the results from methods that are based on the imbibition of 839 
a liquid. It is therefore of great importance to know the limitations of each technique when interpreting 840 
the results, especially for materials that deviate from idealised model systems.  841 
9. Conclusion	842 
Developing a better understanding of the relationship between the raw materials, process settings, 843 
properties of intermediate products and the performance of the finished product requires highly 844 
sophisticated techniques to determine key properties of the material at each stage. This cannot be solved 845 
by one single technique, but it requires the use of the most appropriate method to determine critical 846 
material and quality attributes. We hope that this review has provided an insight into the basic working 847 
principles, the capabilities as well as the limitations and pitfalls of each technique. 848 
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Table 6: Key characteristics of the helium pycnometry, mercury porosimetry, NMR, THz-TDS and XµCT. 849 
 Helium pycnometry Mercury porosimetry NMR THz-TDS XµCT 
Ac
qu
isi
tio
n 
tim
e 
Depending on the number of 
purges performed, typically 
3 minutes per measurement 
for data acquisition and 
processing. 
Depending on the number 
of data points and 
equilibration time – 1 to 3 
hours. 
Depending on the 
spatial resolution – 0.5 
to 1 hour 
Can be as short as a 100 ms. Depending on sample size 
and desired resolution, 
scanning takes minimum 
~30 minutes and up to 
several hours. 
Da
ta
 p
ro
ce
ss
in
g 
tim
e Data can be analysed in under 1 minute. 
Corrections for mercury 
compression and 
penetrometer expansion are 
applied, the elastic response 
of the sample skeletal 
material can be derived at 
highest pressures (Gane et 
al., 1996) – 10 min. 
Data can be analysed in 
under 1 minute. 
Data analysis takes < 1 s per 
measurement. 
Data reconstruction into a 
2D image stack takes 10 – 15 
minutes for a large region of 
interest (depending on 
computer processing power 
and memory), with further 
image segmentation steps 
taking several hours. 
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Ad
va
nt
ag
es
 
- Very accurate technique. 
- Fairly short data acquisition 
and processing times, 
straightforward data 
analysis. 
- Minimal sample 
preparation is needed. 
- Wide range of pore size 
distribution. 
- Total specific pore volume. 
- Bulk modulus value (elastic 
compression of skeletal 
material). 
- Bulk density. 
-Skeletal density. 
- Accesses micropores. 
- Information about 
surface-to-volume ratio 
and tortuosity. 
 
- Very fast, potential for 
process analytics (at-line, 
on-line or even in-line 
application). 
- Provides a measure of 
open and closed pores. 
- Non-invasive, non-
destructive and contactless 
measurement. 
  
- Wide range of data is 
available, from porosity to 
pore size distribution, pore 
shape and anisotropy etc.  
- Visual representation of 
the pore network is 
obtained at high resolution 
(up to 1 µm). Different scale 
models can be combined to 
create a multiscale network. 
- Minimal sample 
preparation is needed. 
- Provides a measure of 
open and closed pores. 
- Non-invasive, non-
destructive and contactless. 
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Lim
ita
tio
ns
 
- Gives limited information 
on the nature of the sample, 
namely just the true density 
and overall porosity. 
- Some materials which give 
off volatiles might be 
unsuitable for the technique, 
or require corrections, even 
after degassing. 
- Must be performed at 
constant temperature for 
ideal gas law to be valid, and 
high enough pressure needs 
to be applied for helium to 
penetrate all the voids. 
- Absorption and/or 
adsorption of a small 
amount of helium in/on the 
solid material may cause a 
measurement error. 
- Accesses only open pores. 
- Destructive measurement. 
- Need for special sample 
disposal. 
- Accesses only open pores. 
 
- Damage of pore 
structure by liquid and 
freezing. 
- Destructive 
measurement for 
typical pharmaceutical 
solid dosage forms. 
- Accesses only open 
pores. 
- A model relating the 
measured effective 
refractive index to the 
porosity has to be 
developed.  
- Sample needs to be 
positioned (in particular for 
biconvex tablets) precisely. 
- Strong absorption of 
terahertz radiation by the 
formulation may limit the 
tablet thickness.  
- Cannot access pore size 
distribution. 
- Sample volume is limited 
by the spot size of the 
terahertz beam (typically 
between 1 - 2 mm in 
diameter).  
- Lengthy data acquisition 
and analysis times.  
- Image segmentation can 
prove difficult depending on 
the sample. Large datasets 
may cause computer 
software to crash. 
Automating the task relieves 
time burden. 
- Managing the large 
amount of data and 
selecting the best 
parameters for each sample 
type can be challenging. 
- Sample size is limited by 
the XµCT machine size. 
850 
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Figure	Captions	1525 
Figure 1: Schematic of different pore structures. The porous materials in both columns have the same 1526 
porosities (!" = !$, !% = !&), but vary in their structures and thus differ in their tortuosities ('(," > '(,$). ' 1527 
is the sample thickness and '(  is the effective streamline length. The single pore representation illustrates 1528 
the description of the pore orientation using eigenvectors. 1529 
Figure 2: Overview of different techniques used to characterise pore structures of pharmaceutical 1530 
materials. AFM: atomic force microscopy; SEM: scanning electron microscopy; TEM: transmission electron 1531 
microscopy; CLSM: confocal laser scanning microscopy; FIB-SEM: focused ion beam SEM; THz-TDS: 1532 
terahertz time-domain spectroscopy; XµCT: X-ray computed microtomography; NMR: nuclear magnetic 1533 
resonance.  1534 
Figure 3: Schematic of the 3D printed disks. A model of the printed disk is depicted in (a), which also 1535 
highlights the volume investigated by XµCT as shown in (b). The dimensions of the subvolume in (b) are 1536 
3.16 x 3.16 x 0.89 mm3 (1 064 x 1 064 x 301 voxels).  1537 
Figure 4: Pore network visualisations classified by pore equivalent diameter for (a) P1 and (b) P2 as well 1538 
as (c) pore size distribution for both samples. 1539 
Figure 5: Orientation of pores, plotted by the largest eigenvector +, and classified by size. Shown for (a, 1540 
b) P1 and (c, d) P2 for two different view angles. The same colour bar applies to all subfigures. Pores larger 1541 
than 1 500 voxels are neglected from the anisotropy analysis, as the simple eigenvalue ratio description 1542 
becomes meaningless. Small pores are largely randomly oriented while the larger pores are oriented at 1543 
an angle of approximately 90° to one another in the -.-plane. 1544 
Figure 6: Cumulative porosity plots (a, b) and porosity by height for (a, c) P1 and (b, d) P2. The pore 1545 
alignment of the large pores as well as the layer structure in the printed object are clearly resolved. 1546 
Figure 7: Blott and Pye charts classified by pore volume for (a, c) P1 and (b, d) P2. (c) and (d) are an 1547 
extension of the Blott and Pye chart to analyse the sphericity of the pores. The same colour bar applies to 1548 
all subfigures. 1549 
Figure 8: Experimental set-up for the helium pycnometry measurement. 1550 
Figure 9: Overview of mercury porosimetry: (a) schematic of the setup, (b) cumulative pore intrusion 1551 
volume, /, as a function of the pore diameter, 01,	and (c) pore volume size distributions of one tablet per 1552 
batch. The samples analysed were pure FCC tablets. More details about the samples can be found in the 1553 
supporting information. 1554 
Figure 10: Schematic of mercury porosimetry, showing the impact of pore wall material compression at 1555 
the highest intrusion pressures (Gane et al., 1996; Ridgway et al., 2017).  1556 
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Figure 11: NMR cryoporometry: (a) schematic of a setup as used by Valckenborg, Pel and Kopinga, 2002, 1557 
to measure the surface-to-volume ratio by cryoporometry and relaxometry of silica gels. Example data of 1558 
porous biodegradable polymer microparticles after swelling for 1 day from Petrov et al., 2006 are 1559 
illustrated in (b) and (c). The data shown here correspond to the sample F in Petrov et al., 2006: (b) 1560 
normalised intensity of non-frozen water in the porous particles as a function of temperature, and (c) 1561 
pore size distribution in the microparticle after swelling for 1 day. 1562 
Figure 12: Data from NMR diffusometry and relaxometry from Collins et al., 2007: (a) signal attenuation 1563 
plot for drug-loaded pellets, (b) surface-to-volume (S/V) ratio and tortuosity as a function of immersion 1564 
time from NMR diffusometry measurements, (c) distribution of the 3$ (spin-spin) relaxation time, and (c) 1565 
pore size distribution calculated from the 3$ relaxation time measurements.  1566 
Figure 13: Workflow for XµCT porosity analysis, with examples of machines and software in brackets. The 1567 
first section is experimental, and the next three are computational steps. 1568 
Figure 14: Measurement setup of XµCT using a cone-beam configuration. 1569 
Figure 15: Schematic of the measurement principle of THz-TDS. The time delay of the terahertz pulse is 34 1570 
and 35 for the sample and the reference waveform, respectively. 1571 
Figure 16: Effective refractive index, 6eff, as a function of the porosity, !THz, from THz-TDS measurements. 1572 
The different samples are composed of porous FCC (M01), potato starch acetate (SA, M02), MCC with 1573 
10% indomethacin (IM), MCC compacts prepared by varying the IM concentration, tablet thickness and 1574 
porosity simultaneously (M03). The complex formulation M04 consisted of a BCS class II drug and four 1575 
excipients. More details about the samples are provided in the supporting information.  1576 
Figure 17: Correlation between the porosity calculated from THz-TDS (!THz) measurements and from 1577 
helium pycnometry (!He-Pyc) for FCC tablets (set M01). !THz was calculated using the anisotropic 1578 
Bruggeman model and an intrinsic refractive index of 2.97. Helium pycnometry was used to determine 1579 
the true density (@true,FCC = 2.958 g cm-3) of FCC. More details about the samples are provided in the 1580 
supporting information.  1581 
Figure 18: Porosity calculated from mercury porosimetry (!MP), helium pycnometry (!He-Pyc), and THz-TDS 1582 
measurements (!THz) of MCC/indomethacin tablets. More details about the samples are provided in the 1583 
supporting information.  1584 
 1585 
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